Pembrolizumab vs Sodium Pertechnetate
Pembrolizumab vs Sodium Pertechnetate: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Sodium Pertechnetate.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days.
Chemical Properties
Type: Pembrolizumab — Antibody; Sodium Pertechnetate — Small molecule.